Total Payments
$131,628
2024 Payments
$29,446
Companies
57
Transactions
2,036
Medicare Patients
7,585
Medicare Billing
$5.9M
Payment Breakdown by Category
Other$95,079 (72.2%)
Food & Beverage$32,549 (24.7%)
Travel$2,286 (1.7%)
Consulting$950.00 (0.7%)
Education$764.57 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $94,839 | 56 | 72.1% |
| Food and Beverage | $32,549 | 1,938 | 24.7% |
| Travel and Lodging | $2,286 | 20 | 1.7% |
| Consulting Fee | $950.00 | 2 | 0.7% |
| Education | $764.57 | 19 | 0.6% |
| Grant | $239.52 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $71,766 | 312 | $0 (2024) |
| Janssen Biotech, Inc. | $38,889 | 575 | $0 (2024) |
| Amgen Inc. | $3,081 | 171 | $0 (2024) |
| PFIZER INC. | $1,959 | 157 | $0 (2024) |
| Lilly USA, LLC | $1,811 | 116 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,727 | 86 | $0 (2024) |
| UCB, Inc. | $1,715 | 102 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $1,160 | 2 | $0 (2024) |
| GlaxoSmithKline, LLC. | $978.69 | 67 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $789.64 | 41 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $29,446 | 223 | Janssen Biotech, Inc. ($13,895) |
| 2023 | $36,909 | 248 | Janssen Biotech, Inc. ($19,958) |
| 2022 | $20,890 | 296 | ABBVIE INC. ($17,173) |
| 2021 | $4,102 | 282 | Janssen Biotech, Inc. ($1,563) |
| 2020 | $5,019 | 186 | AbbVie Inc. ($2,906) |
| 2019 | $16,472 | 280 | AbbVie, Inc. ($13,320) |
| 2018 | $9,600 | 266 | AbbVie, Inc. ($6,532) |
| 2017 | $9,189 | 255 | AbbVie, Inc. ($6,582) |
All Payment Transactions
2,036 individual payment records from CMS Open Payments — Page 1 of 82
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Dermatology | ||||||
| 12/19/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 12/18/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $28.15 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $27.40 | General |
| Category: Inflammation | ||||||
| 12/16/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $425.00 | General |
| 12/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $31.38 | General |
| Category: Immunology | ||||||
| 12/14/2024 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological), TREMFYA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,475.00 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Organon Llc | RENFLEXIS (Drug), HADLIMA | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: INFLIXIMAB | ||||||
| 12/11/2024 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological), TREMFYA | Food and Beverage | In-kind items and services | $55.08 | General |
| Category: Immunology | ||||||
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.37 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $30.29 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/03/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.98 | General |
| Category: IMMUNOLOGY | ||||||
| 11/28/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/26/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 11/25/2024 | Sandoz Inc. | HYRIMOZ (Biological) | Food and Beverage | In-kind items and services | $31.50 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $31.56 | General |
| Category: Immunology | ||||||
| 11/16/2024 | Janssen Scientific Affairs, LLC | — | Food and Beverage | In-kind items and services | $60.00 | General |
| 11/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.62 | General |
| Category: Immunology | ||||||
| 11/14/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $4.74 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.33 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 1,851 | 143,339 | $3.4M | $1.6M |
| 2022 | 26 | 2,070 | 126,174 | $3.3M | $1.6M |
| 2021 | 24 | 1,872 | 85,076 | $2.4M | $1.2M |
| 2020 | 24 | 1,792 | 81,072 | $3.0M | $1.5M |
Total Patients
7,585
Total Services
435,661
Medicare Billing
$5.9M
Procedure Codes
100
All Medicare Procedures & Services
100 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 21 | 9,325 | $662,075 | $314,153 | 47.4% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 142 | 13,860 | $343,501 | $253,011 | 73.7% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2023 | 33 | 21,100 | $569,700 | $217,989 | 38.3% |
| J3262 | Injection, tocilizumab, 1 mg | Office | 2023 | 14 | 43,675 | $305,725 | $204,038 | 66.7% |
| J9312 | Injection, rituximab, 10 mg | Office | 2023 | 14 | 2,800 | $344,400 | $177,306 | 51.5% |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 11 | 33,200 | $365,200 | $129,274 | 35.4% |
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2023 | 17 | 15,541 | $186,492 | $123,437 | 66.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 395 | 635 | $171,595 | $59,143 | 34.5% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 91 | 442 | $152,490 | $47,586 | 31.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 465 | 619 | $113,896 | $38,711 | 34.0% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 169 | 553 | $104,017 | $31,253 | 30.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 71 | 71 | $29,465 | $8,514 | 28.9% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 29 | 167 | $18,370 | $3,838 | 20.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 27 | 27 | $7,371 | $2,089 | 28.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 33 | 37 | $6,475 | $1,751 | 27.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 14 | $5,096 | $1,709 | 33.5% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 25 | 25 | $6,565 | $1,252 | 19.1% |
| 20550 | Injection into tendon or ligament | Office | 2023 | 26 | 36 | $5,400 | $1,206 | 22.3% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2023 | 24 | 120 | $1,680 | $737.52 | 43.9% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 15 | 31 | $2,158 | $695.42 | 32.2% |
| 20600 | Aspiration and/or injection of fluid from small joint | Office | 2023 | 14 | 18 | $2,430 | $552.58 | 22.7% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2023 | 115 | 921 | $921.00 | $452.19 | 49.1% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 43 | 54 | $648.00 | $206.57 | 31.9% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 17 | 23 | $920.00 | $170.37 | 18.5% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2023 | 15 | 30 | $1,800 | $123.79 | 6.9% |
About Dr. Raphael Kieval, MD
Dr. Raphael Kieval, MD is a Rheumatology healthcare provider based in Brockton, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1730155029.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Raphael Kieval, MD has received a total of $131,628 in payments from pharmaceutical and medical device companies, with $29,446 received in 2024. These payments were reported across 2,036 transactions from 57 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($94,839).
As a Medicare-enrolled provider, Kieval has provided services to 7,585 Medicare beneficiaries, totaling 435,661 services with total Medicare billing of $5.9M. Data is available for 4 years (2020–2023), covering 100 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Other Specialties Internal Medicine
- Location Brockton, MA
- Active Since 02/27/2006
- Last Updated 12/19/2011
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1730155029
Products in Payments
- RINVOQ (Biological) $32,165
- SIMPONI ARIA (Biological) $24,860
- TREMFYA (Drug) $14,088
- SKYRIZI (Biological) $8,028
- Rinvoq (Biological) $6,233
- Humira (Biological) $4,442
- RINVOQ (Drug) $2,817
- Enbrel (Biological) $1,759
- Cimzia (Drug) $1,534
- TALTZ (Drug) $1,529
- XELJANZ (Drug) $1,501
- Otezla (Drug) $1,049
- COSENTYX (Biological) $992.49
- BENLYSTA (Biological) $869.80
- ORENCIA (Biological) $789.64
- STELARA (Biological) $740.49
- COSENTYX (Drug) $698.39
- KRYSTEXXA (Biological) $688.53
- SAPHNELO (Biological) $672.59
- ACTHAR (Biological) $624.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.